Results 121 to 123 of about 9,405 (123)
Novel biomarker emergence plays a critical role in improving CHB management. Advances in sensitive detection methods, AI, and large‐scale data platforms have independently contributed to biomarkers while driving the development of multi‐omics approaches.
Yaru Shi, Rong Fan
wiley +1 more source
Abstract Motor vehicle collisions are among the leading causes of unintended injury‐related deaths among children under the age of 14. The primary cause of these deaths is the improper use of child passenger safety restraints (CPSRs). Correctly installed CPSRs can decrease the risk of fatal injury by 45% to 95%.
Kimberley L. M. Zonneveld+2 more
wiley +1 more source
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley +1 more source